CD40LG and neutropenia: Hentrich et al. [121] used intravenous IgM- and IgA-enriched IVIG (IVIGMA) to treat sepsis patients with neutropenia from chemotherapy, and found that IVIGMA treatment did not improve the prognosis of those patients.